Electra D. Paskett, Ph.D., became the Marion N. Rowley Professor of Cancer Research at The Ohio State University in 2002. She is the Director of the Division of Cancer Prevention and Control in the College of Medicine, a professor in the Division of Epidemiology in the College of Public Health and the Associate Director for Population Sciences and Program Leader of the Cancer Control Program in the Comprehensive Cancer Center of the Ohio State University (OSU). She is also Director of the Center for Cancer Health Equity at the James Cancer Hospital. Dr. Paskett’s research program is nationally recognized for studying cancer health disparities. The program has four major areas of focus and has evolved to utilize a "team science approach" to understanding and intervening in these problems: energy balance and cancer prevention; promoting the use of early-detection exams; improving access to diagnostic and treatment services; and lymphedema prevention.
Industry Expertise (2)
Areas of Expertise (4)
University of Washington: Ph.D., Epidemiology
Media Appearances (5)
More than 40% of U.S. adults carry HPV; 20% have the cancer-causing kind, report says
Lingering misconceptions and fears are among the reasons for the lower HPV vaccine uptake, said Electra Paskett, a cancer control researcher at The Ohio State University Comprehensive Cancer Center. Some people still think vaccination encourages youth to become promiscuous. "The way [the vaccine] was introduced in Australia and the United Kingdom was as a cancer vaccine, which is truly what it is. It is a cancer vaccine," Paskett said...
Exercise does not prevent lymphedema in breast cancer
"Poor adherence in the education-plus-exercise arm may have been a factor," said lead author Electra Paskett, PhD, from the Ohio State University Comprehensive Cancer Center, Columbus. "We are now in the process of doing a more in-depth analysis of quality of life and symptom data by intervention arm and lymphedema status."
‘It’s a form of prevention,’ doctors tout HPV vaccine in fight against several cancers
CBS New York
“We have less than 50 percent of girls who are completing the vaccine series and about 28 percent of boys,” Dr. Electra Paskett, Ohio State University Comprehensive Cancer Center, explained...
Cancer "moonshot" plan is bold, but is it realistic?
“We want to make sure we really utilize the technology we now have to identify people at higher genetic risk,” Dr. Electra Paskett told CBS News. Paskett is co-leader of the cancer control research program at The Ohio State University Comprehensive Cancer Center and was recently nominated by President Obama as a member of the National Cancer Advisory Board, the group the Blue Ribbon committee presented their plan to yesterday...
Breaking the cycle of despair
Last month, cancer epidemiologist Electra Paskett rode through this southeastern Ohio town in a borrowed Dodge minivan determined to do something about that.
“This isn’t fair for people,” she said, pausing alongside a ramshackle home with peeling paint, cracked windows, and an empty pizza box on the front porch. “The last thing on their minds is health care because they’re trying to make ends meet.”...
Recent Research (2)
Balkrishnan and Bhosle conducted the study with Electra Paskett, the Marion N. Rowley Professor of Cancer Research in the School of Public Health at Ohio State and other colleagues from Ohio State and the University of Texas School of Public Health.
Our results show that lay health advisers can improve the rates of mammography screening among low-income, rural white, African-American and Native American women, says principal investigator Electra D. Paskett, who is a professor in the College of Medicine and School of Public Health at Ohio State.